Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage (2026-06-08)
Novo Nordisk and Eli Lilly bring their longtime rivalry to GLP-1 pills and prepare to make their pitch to seniors with Medicare.